AMY BIRD: Open Payments
NPI 1598082679 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$529 in 16 payments from 10 companies in 2025. Trend: 2023 $210 · 2024 $285 · 2025 $529
Food & beverage: $529
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 2 | $250 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Inspire Medical Systems, Inc. | 3 | $61 |
| Vifor Pharma, Inc. | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Philips North America LLC | 1 | $22 |
| United Therapeutics Corporation | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| Viatris Specialty LLC | 1 | $14 |
Products named: INSPIRE, FASENRA, Zemaira, AIRSUPRA, DUPIXENT, UPTRAVI, Home PI Undivided, Tyvaso.
Industry payments across TX — which companies pay providers there.
